Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Shabet Rose Sharon
Relationship:  
City:   Greenwich
State:   CT
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   0    

Indirect Shares

   415,583,308      
Direct Value   $0    

Indirect Value

   $3,673,520,169      
Total Shares   415,583,308      
Total Value   $3,673,520,169      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    8    

     Stock price went up :
    1   
    2    
     Stock price went down :
    0   
    6    
   
     Gain/Loss Ratio :
   1.0   
   1.0   
     Percentage Gain/Loss :
   183.9%
 -164.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Tekmira Pharmaceuticals Corp TKMR 10% Owner 0 2017-07-01 16,013,540    Premium*  
            Sio Gene Therapies Inc SIOX 10% Owner 0 2019-03-18 105,952,381    Premium*  
            Myovant Sciences Ltd. MYOV 10% Owner 0 2019-06-04 40,765,599    Premium*  
            Urovant Sciences Ltd. UROV 10% Owner 2018-10-01 0 2019-06-19 22,860,013    Premium*  
            Adaptive Biotechnologies Corp ADPT 10% Owner 0 2020-12-14 29,993,708    Premium*  
            Bridgebio Pharma, Inc. BBIO 2019-06-27 0 2023-07-18 25,120,991    Premium*  
            Zentalis Pharmaceuticals, Llc ZNTL 10% Owner 0 2020-12-01 3,943,284    Premium*  
            Inhibrx, Inc. INBX 2020-08-24 0 2023-08-28 7,150,826    Premium*  
            4d Molecular Therapeutics Inc. FDMT 2020-12-15 0 2024-01-04 4,247,914    Premium*  
            Rallybio Corp RLYB 10% Owner 2021-07-29 0 2021-07-29 4,194,777    Premium*  
            Figs, Inc. FIGS 10% Owner 2021-09-02 0 2021-09-03 14,742,689    Premium*  
            Procept Biorobotics Corp PRCT 0 2021-09-14 308,142    Premium*  
            Ginkgo Bioworks Holdings, Inc DNA 0 2022-03-02 51,055,144    Premium*  
            Amylyx Pharmaceuticals, Inc. AMLX 2022-01-11 0 2022-01-11 2,300,000    Premium*  
            Frazier Lifesciences Acquisition... FLAC 2022-11-02 0 2022-11-02 1,211,582    Premium*  
            Rayzebio, Inc. RYZB 2023-09-19 0 2024-02-26 0    Premium*  
            Api Group Corp APG 2024-01-02 0 2024-03-05 27,071,548    Premium*  
            Fluidigm Corp FLDM 0 2024-03-18 58,651,170    Premium*  
* Premium Members only  

Records found :    74         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-05-17 4 AB $7.36 $45,641 I/I 6,200 0 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-05-20 4 AB $7.98 $80,525 I/I 10,000 0 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-05-23 4 AB $7.76 $37,252 I/I 4,802 0 0 -
RYZB Rayzebio, Inc.   •       •       •   2024-02-26 4 D $0.00 $0 I/I (6,642,700) 0 0 -
APG Api Group Corp   •       •       •   2024-01-02 4 S $31.30 $203,450,000 I/I (6,500,000) 17,088 0 %
APG Api Group Corp   •       •       •   2024-03-05 4 S $34.25 $104,072,632 I/I (3,038,617) 39,032 0 %
APG Api Group Corp   •       •       •   2024-02-28 4 D $36.90 $149,999,939 I/I (4,065,039) 99,804 0 -
APG Api Group Corp   •       •       •   2024-02-28 4 OE $24.60 $201,741,599 I/I 8,200,878 181,104 0 -
PRCT Procept Biorobotics Corp   –       –       •   2021-09-14 3 IO $0.00 $0 I/I 0 308,142 -
INBX Inhibrx, Inc.   •       •       •   2022-10-07 4 B $30.00 $39,999,857 I/I 1,333,333 333,333 0.01 -
INBX Inhibrx, Inc.   •       •       •   2023-08-28 4 B $19.35 $9,899,982 I/I 511,627 511,627 0.01 -
INBX Inhibrx, Inc. 10% Owner   –       –       •   2020-08-24 4 B $19.43 $897,001 I/I 46,161 1,161,784 1.5 -
FLAC Frazier Lifesciences Acqu...   •       •       •   2022-11-02 4 B $10.08 $8,538,385 I/I 847,062 1,211,582 0.01 -
INBX Inhibrx, Inc. 10% Owner   –       –       •   2020-08-25 4 B $19.23 $1,651,687 I/I 85,304 1,247,088 1.5 -
RYZB Rayzebio, Inc.   •       •       •   2023-09-19 4 A $0.00 $0 I/I 5,253,811 1,285,223 0 -
ADPT Adaptive Biotechnologies ... 10% Owner   –       –       •   2019-06-26 3 IO $0.00 $0 I/I 0 1,425,000 -
INBX Inhibrx, Inc. 10% Owner   –       –       •   2020-08-26 4 B $18.84 $3,409,866 I/I 180,219 1,427,307 1.5 -
ADPT Adaptive Biotechnologies ... 10% Owner   –       –       •   2019-07-01 4 B $20.00 $5,000,000 I/I 250,000 1,675,000 1.5 -
RYZB Rayzebio, Inc.   •       •       •   2023-09-19 4 B $18.00 $25,000,002 I/I 1,388,889 1,743,556 0.01 %
AMLX Amylyx Pharmaceuticals, I...   •       •       •   2022-01-11 4 B $19.00 $43,700,000 I/I 2,300,000 2,300,000 0.01 -
FDMT 4d Molecular Therapeutics... 10% Owner   –       –       •   2020-12-15 4 A $0.00 $0 I/I 2,837,914 2,837,914 0 -
RLYB Rallybio Corp 10% Owner   –       –       •   2021-07-29 4 A $0.00 $0 I/I 3,388,777 3,388,777 0 -
ZNTL Zentalis Pharmaceuticals,... 10% Owner   –       –       •   2020-04-03 3 IO $0.00 $0 I/I 0 3,718,284 -
FDMT 4d Molecular Therapeutics... 10% Owner   –       –       •   2020-12-15 4 B $23.00 $25,300,000 I/I 1,100,000 3,937,914 1.5 -
ZNTL Zentalis Pharmaceuticals,... 10% Owner   –       –       •   2020-12-01 4 S $50.50 $25,250,000 I/I (500,000) 3,943,284 0 -
  74  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us